Years of caring for children with solid tumors and looking into the eyes of parents starved for hope have led Catherine Bollard to what she calls the most important moment of her career. Children’s ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

New research found only 15% of cancer survivors discussed clinical trials with their healthcare team. Fact checked by Nick Blackmer Cancer deaths have dropped by 33% over the last three decades, in ...

How do you Access Cancer Clinical Trials? Tiffany Colvin, CCRP Sr. Director Clinical Trial Operations, Fred Hutch Cancer Center— another presenter — emphasized the dedication of the people involved in ...

Semagacestat, tramiprosate, tarenflurbil, latrepirdine: These names may not mean a lot to you, but all four of them were high-profile would-be Alzheimer’s drugs that — in the last two to three years — ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...

Share on Pinterest Actor Rob Lowe has teamed up with Eli Lilly to encourage more people to participate in cancer clinical trials. Photography courtesy of Rob Lowe Rob Lowe shares how three generations ...

Experts say a lack of participation in clinical trials is one reason Black women are 38% more likely to die from breast cancer. A simple question sparked complicated answers: “Would you participate in ...

Fewer than 20% of eligible patients decide to participate in clinical trials, and national surveys suggest that willingness to do so is declining still further. New research published in JCO Oncology ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...